4l4r: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
<StructureSection load='4l4r' size='340' side='right' caption='[[4l4r]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
<StructureSection load='4l4r' size='340' side='right' caption='[[4l4r]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4l4r]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L4R OCA]. <br>
<table><tr><td colspan='2'>[[4l4r]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L4R OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L4R FirstGlance]. <br>
</td></tr><tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4l4s|4l4s]]</td></tr>
</td></tr><tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4l4s|4l4s]]</td></tr>
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span></td></tr>
<tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">LDHA, PIG19 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/L-lactate_dehydrogenase L-lactate dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.27 1.1.1.27] </span></td></tr>
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l4r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l4r OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l4r RCSB], [http://www.ebi.ac.uk/pdbsum/4l4r PDBsum]</span></td></tr>
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l4r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l4r OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l4r RCSB], [http://www.ebi.ac.uk/pdbsum/4l4r PDBsum]</span></td></tr>
<table>
<table>
Line 11: Line 12:
== Function ==
== Function ==


<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Lactate dehydrogenase A (LDH-A) is a key enzyme in anaerobic respiration that is predominantly found in skeletal muscle and catalyses the reversible conversion of pyruvate to lactate in the presence of NADH. LDH-A is overexpressed in many tumours and has therefore emerged as an attractive target for anticancer drug discovery. Crystal structures of human LDH-A in the presence of inhibitors have been described, but currently no structures of the apo or binary NADH-bound forms are available for any mammalian LDH-A. Here, the apo structure of human LDH-A was solved at a resolution of 2.1 A in space group P4122. The active-site loop adopts an open conformation and the packing and crystallization conditions suggest that the crystal form is suitable for soaking experiments. The soaking potential was assessed with the cofactor NADH, which yielded a ligand-bound crystal structure in the absence of any inhibitors. The structures show that NADH binding induces small conformational changes in the active-site loop and an adjacent helix. A comparison with other eukaryotic apo LDH structures reveals the conservation of intra-loop interactions. The structures provide novel insight into cofactor binding and provide the foundation for soaking experiments with fragments and inhibitors.
Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase.,Dempster S, Harper S, Moses JE, Dreveny I Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1484-90. doi:, 10.1107/S1399004714005422. Epub 2014 Apr 30. PMID:24816116<ref>PMID:24816116</ref>
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
</div>
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: L-lactate dehydrogenase]]
[[Category: L-lactate dehydrogenase]]
[[Category: Dempster, S.]]
[[Category: Dempster, S.]]

Revision as of 07:41, 4 June 2014

Structural Characterisation of the Apo-form of Human Lactate Dehydrogenase M IsozymeStructural Characterisation of the Apo-form of Human Lactate Dehydrogenase M Isozyme

Structural highlights

4l4r is a 2 chain structure with sequence from Human. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Related:4l4s
Gene:LDHA, PIG19 (HUMAN)
Activity:L-lactate dehydrogenase, with EC number 1.1.1.27
Resources:FirstGlance, OCA, RCSB, PDBsum

Disease

[LDHA_HUMAN] Defects in LDHA are the cause of glycogen storage disease type 11 (GSD11) [MIM:612933]. A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue.[1]

Function

Publication Abstract from PubMed

Lactate dehydrogenase A (LDH-A) is a key enzyme in anaerobic respiration that is predominantly found in skeletal muscle and catalyses the reversible conversion of pyruvate to lactate in the presence of NADH. LDH-A is overexpressed in many tumours and has therefore emerged as an attractive target for anticancer drug discovery. Crystal structures of human LDH-A in the presence of inhibitors have been described, but currently no structures of the apo or binary NADH-bound forms are available for any mammalian LDH-A. Here, the apo structure of human LDH-A was solved at a resolution of 2.1 A in space group P4122. The active-site loop adopts an open conformation and the packing and crystallization conditions suggest that the crystal form is suitable for soaking experiments. The soaking potential was assessed with the cofactor NADH, which yielded a ligand-bound crystal structure in the absence of any inhibitors. The structures show that NADH binding induces small conformational changes in the active-site loop and an adjacent helix. A comparison with other eukaryotic apo LDH structures reveals the conservation of intra-loop interactions. The structures provide novel insight into cofactor binding and provide the foundation for soaking experiments with fragments and inhibitors.

Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase.,Dempster S, Harper S, Moses JE, Dreveny I Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1484-90. doi:, 10.1107/S1399004714005422. Epub 2014 Apr 30. PMID:24816116[2]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Maekawa M, Sudo K, Kanno T, Li SS. Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem Biophys Res Commun. 1990 Apr 30;168(2):677-82. PMID:2334430
  2. Dempster S, Harper S, Moses JE, Dreveny I. Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1484-90. doi:, 10.1107/S1399004714005422. Epub 2014 Apr 30. PMID:24816116 doi:http://dx.doi.org/10.1107/S1399004714005422

4l4r, resolution 2.10Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA